Press
Releases
Title
Date
Download PDF
PUF Ventures Announces Proposed Name Change and Forward Split
11/07/2018
PUF Ventures Closes $12.5 Million First Tranche of $40 Million Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
10/18/2018
PUF Ventures Joins the Cannvas Marché Program as First Licensed Producer
10/16/2018
PUF Ventures’ Majority Owned Subsidiary Receives Cultivation License from Health Canada
10/15/2018
PUF Ventures Provides Update to Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
10/11/2018
PUF Ventures Congratulates Cannvas MedTech on the Launch of Cannvas.Me
10/09/2018
PUF Ventures and Natures Hemp Applaud Health Canada Changes to Industrial Hemp Regulations
08/15/2018
PUF Ventures Announces the Court Approval of the Plan of Arrangement and Closing of First Tranche of $0.25 Special Warrant Private Placement
08/14/2018
PUF Ventures Reports Special Meeting Results
08/08/2018
PUF Ventures Inc. Announces Update to Natures Hemp Special Warrant Financing
08/03/2018
PUF Ventures Provides Update Regarding the Business of Natures Hemp Corp.
07/18/2018
PUF Ventures Engages Cannabis Compliance Inc. for Large-scale Greenhouse Facility in Delta, BC
07/05/2018
PUF Ventures Brings Large-Scale Propagation to the Canadian Cannabis Industry – Existing 2.2 Million Sq. Ft. Facility Used to Propagate Flower Ready Cannabis Plants
07/03/2018
PUF Ventures Inc. & Houweling’s Group, form Propagation Services Canada Inc. within a 2.2 million sq. ft. existing facility.
06/29/2018
PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities
05/04/2018
Dr. Peter Tolias, PhD Joins PUF Ventures’ Advisory Board
04/26/2018
Australian Governments to Streamline Access to Medical Cannabis.
04/24/2018
Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board
04/24/2018
PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
04/18/2018
PUF Ventures Inc. Announces a Plan to Spin Out its Subsidiary Natures Hemp Inc.
04/04/2018